| What if biosensors could help treat rare diseases? |
|---|
| Most rare diseases are incurable. Research into new diagnostics and therapies is hampered by the low number of patients, limited amount of data, lack of multi-centre coordination and low profitability. Biosensors are a technology that, driven by continuous advances in artificial intelligence, can help disease detection, lower the cost of novel therapies, replace placebo groups in clinical trials and foster patient-centred, personalised (e)-medicine. Governance of biosensor technology involves targeted action addressing various EU laws and policies. |
No abstract for this publication.
|
- Publication type:
- policy brief
- Publication language:
- English
- Publication date:
- 2023-06
- Publication URL:
- https://www.europarl.europa.eu/RegData/etudes/ATAG/2023/747441/EPRS_ATA(2023)747441_EN.pdf
- Institute:
- European Parliament / Panel for the Future of Science and Technology (STOA) (STOA)
- Country:
- EU
